Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	MPOS	POSD
	ARID1A(0.9%)	exon16,c.3999G>A,p.Q1333=	0.008762	0.004182	736|7	281|0	0.00896	1217|11	1	27100203	27100203	G	A	background	ARID1A	NM_006015.6	16	c.3999G>A	p.Gln1333=	synonymous_variant				45	0.0
1	NRAS(0.1%)	exon4,c.437C>T,p.A146V	0.001459	0.000604	7473|12	3357|2	0.00109	34688|38	1	115252203	115252203	G	A	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	4	c.437C>T	p.Ala146Val	missense_variant				37	0.0
1	NRAS(0.0%)	exon4,c.436G>T,p.A146S	0.0002459	0.0003655	7467|3	3338|1	0.00101	34635|35	1	115252204	115252204	C	A	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>T	p.Ala146Ser	missense_variant				50	0.0
1	NRAS(0.0%)	exon4,c.436G>C,p.A146P	0.0003604	0.0003938	7467|3	3338|2	0.00092	34635|32	1	115252204	115252204	C	G	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>C	p.Ala146Pro	missense_variant				72	0.0
1	NRAS(0.1%)	exon4,c.436G>A,p.A146T	0.0007534	0.0003649	7467|6	3338|0	0.00072	34635|25	1	115252204	115252204	C	T	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>A	p.Ala146Thr	missense_variant				20	0.0
1	NRAS(0.0%)	exon3,c.183A>T,p.Q61H	0.0004672	0.0008332	3885|3	2322|3	0.00133	16466|22	1	115256528	115256528	T	A	base_qual,clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	3	c.183A>T	p.Gln61His	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Uncertain_significance(1)	Hepatocellular_carcinoma|Acute_myeloid_leukemia|Melanoma|Adrenocortical_carcinoma|B-cell_chronic_lymphocytic_leukemia|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Adenocarcinoma_of_stomach|Neoplasm_of_the_thyroid_gland|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Ovarian_Serous_Cystadenocarcinoma|Glioblastoma|Noonan_syndrome_and_Noonan-related_syndrome|Malignant_neoplasm_of_body_of_uterus|not_provided	48	0.0
1	NRAS(0.0%)	exon2,c.38G>A,p.G13D	0.0004753	0.000665	8248|4	4253|2	0.00032	40324|13	1	115258744	115258745	C	T	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.38G>A	p.Gly13Asp	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Melanoma|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Malignant_melanoma_of_skin|Juvenile_myelomonocytic_leukemia|Non-Hodgkin_lymphoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|RAS-associated_autoimmune_leukoproliferative_disorder|Myelodysplastic_syndrome|Acute_megakaryoblastic_leukemia_in_down_syndrome|not_provided	30	0.0
1	NRAS(0.0%)	exon2,c.37G>A,p.G13S	0.0004378	0.0004474	8259|3	4257|3	0.00052	40521|21	1	115258745	115258745	C	T	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	2	c.37G>A	p.Gly13Ser	missense_variant	Likely_pathogenic		Neoplasm_of_stomach	44	0.0
	LCE4A(0.2%)	exon1,c.64C>T,p.P22S	0.002328	0.000924	4026|10	1417|0	0.00202	12831|26	1	152681615	152681615	C	T	background,low_allele_frac	LCE4A	NM_178356.3	1	c.64C>T	p.Pro22Ser	missense_variant				53	0.0
	SLAMF1(41.7%)	exon6,c.912del,p.A305fs	0.417	0.027	2286|1698	1454|51	0.39242	8062|5207	1	160589600	160589601	CT	C	multiallelic,distinguished	SLAMF1	NM_001330754.2	6	c.912del	p.Ala305fs	frameshift_variant				42	0.0
	FMN2(19.6%)	exon5,c.2973A>T,p.P991=	0.196	0.05	43|9	19|0	0.15086	197|35	1	240371085	240371085	A	T	suspected_bg	FMN2	NM_020066.5	5	c.2973A>T	p.Pro991=	synonymous_variant				12	0.0
	FMN2(15.5%)	exon5,c.2985_2988delinsAGGA,p.997	0.155	0.1	41|6	10|0	0.01923	102|2	1	240371097	240371100	GGGC	AGGA	PASS	FMN2	NM_020066.5	5	c.2985_2988delinsAGGA	p.997	synonymous_variant				7	0.0
	TAF1B(21.4%)	exon3,c.196_197del,p.N66fs	0.214	0.014	1093|383	531|11	0.22429	3002|868	2	9989570	9989573	TAAA	TA	multiallelic	TAF1B	NM_005680.3	3	c.196_197del	p.Asn66fs	frameshift_variant				39	0.0
	TAF1B(10.8%)	exon3,c.197del,p.N66fs	0.108	0.095	1093|206	531|73	0.12299	3002|421	2	9989570	9989573	TAAA	TAA	multiallelic,suspected_bg	TAF1B	NM_005680.3	3	c.197del	p.Asn66fs	frameshift_variant				41	0.0
	TAF1B(3.8%)	exon3,c.197dup,p.N66fs	0.038	0.073	1093|93	531|64	0.07773	3002|253	2	9989570	9989573	TAAA	TAAAA	multiallelic,suspected_bg	TAF1B	NM_005680.3	3	c.197dup	p.Asn66fs	frameshift_variant				40	0.0
	MYCN(16.8%)	exon3,c.1225C>T,p.P409S	0.168	0.027	107|21	38|0	0.14024	141|23	2	16086049	16086049	C	T	PASS	MYCN	NM_005378.6	3	c.1225C>T	p.Pro409Ser	missense_variant				33	0.0
-	MSH2(13.3%)	exon2,c.212-5_212-4del	0.133	0.045	311|86	66|3	0.13659	708|112	2	47635523	47635525	CTT	C	multiallelic,normal_artifact	MSH2	NM_000251.3	1	c.212-5_212-4del		splice_region_variant&intron_variant				39	0.0
-	MSH2(30.0%)	exon2,c.212-4del	0.3	0.137	311|200	66|17	0.32700	708|344	2	47635523	47635525	CTT	CT	multiallelic,normal_artifact,distinguished	MSH2	NM_000251.3	1	c.212-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome_I|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	42	0.0
-	MSH2(7.5%)	exon2,c.212-4dup	0.075	0.099	311|53	66|13	0.12808	708|104	2	47635523	47635525	CTT	CTTT	multiallelic,normal_artifact,suspected_bg	MSH2	NM_000251.3	1	c.212-4dup		splice_region_variant&intron_variant	Benign		Lynch_syndrome_I|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer	42	0.0
-	MSH6(8.0%)	exon5,c.3261del,p.F1088fs	0.08	0.051	4618|452	1358|73	0.06181	15832|1043	2	48030639	48030640	AC	A	normal_artifact,slippage,suspected_bg	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Lynch-like_syndrome|Endometrial_carcinoma|Carcinoma_of_colon|Lynch_syndrome|Hereditary_nonpolyposis_colorectal_cancer_type_5|Hereditary_cancer-predisposing_syndrome|Mismatch_repair_cancer_syndrome_3|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided	42	0.0
-	MSH6(16.9%)	exon5,c.3312dup,p.G1105fs	0.169	0.005064	3444|713	1192|7	0.15306	11056|1998	2	48030691	48030691	C	CT	multiallelic	MSH6	NM_000179.3	5	c.3312dup	p.Gly1105fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|not_provided	37	0.0
-	MSH6(0.7%)	exon5,c.3311_3312dup,p.G1105fs	0.006615	0.0009484	3444|29	1192|1	0.00692	11056|77	2	48030691	48030691	C	CTT	multiallelic,low_allele_frac	MSH6	NM_000179.3	5	c.3311_3312dup	p.Gly1105fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|not_provided	61	0.0
-	MSH6(18.3%)	exon7,c.3557-6_3557-4del	0.183	0.108	40|12	7|0	0.11290	55|7	2	48032740	48032743	ATTT	A	multiallelic	MSH6	NM_000179.3	6	c.3557-6_3557-4del		splice_region_variant&intron_variant				53	0.0
-	MSH6(14.4%)	exon7,c.3557-4dup	0.144	0.22	40|7	7|1	0.11290	55|7	2	48032740	48032743	ATTT	ATTTT	multiallelic,suspected_bg	MSH6	NM_000179.3	6	c.3557-4dup		splice_region_variant&intron_variant	Benign		Lynch_syndrome|Hereditary_nonpolyposis_colorectal_cancer_type_5|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	49	0.0
2	RGPD3(0.2%)	exon17,c.2386-1G>T	0.001841	0.0008296	4486|16	1424|1	0.00673	14754|100	2	107049475	107049475	C	A	strand_bias,background,low_allele_frac	RGPD3	NM_001144013.2	16	c.2386-1G>T		splice_acceptor_variant&intron_variant				45	0.0
	LRP1B(20.9%)	exon56,c.9024dup,p.S3009fs	0.209	0.009511	309|74	137|0	0.17627	472|101	2	141253143	141253143	A	AT	PASS	LRP1B	NM_018557.3	56	c.9024dup	p.Ser3009fs	frameshift_variant				42	0.0
	BMPR2(21.1%)	exon12,c.1748del,p.N583fs	0.211	0.012	3070|820	1652|24	0.19012	10049|2359	2	203420129	203420130	GA	G	distinguished	BMPR2	NM_001204.7	12	c.1748del	p.Asn583fs	frameshift_variant	Pathogenic		Pulmonary_arterial_hypertension|Primary_pulmonary_hypertension|Idiopathic_and/or_familial_pulmonary_arterial_hypertension	38	0.0
1	IDH1(0.1%)	exon4,c.394C>T,p.R132C	0.0009957	0.00108	4813|4	2350|2	0.00188	19071|36	2	209113113	209113113	G	A	clustered_events,orientation,strand_bias,weak_evidence	IDH1	NM_005896.4	4	c.394C>T	p.Arg132Cys	missense_variant	Pathogenic/Likely_pathogenic		Hepatocellular_carcinoma|Acute_myeloid_leukemia|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Astrocytoma|Breast_neoplasm|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Adenocarcinoma_of_prostate|Glioblastoma|Myelodysplastic_syndrome|not_provided	44	0.0
	MYL1(19.0%)	exon1,c.-1_1del,p.M1fs	0.19	0.013	974|297	260|3	0.19132	2384|564	2	211179765	211179768	ATTT	AT	multiallelic	MYL1	NM_079420.3	1	c.-1_1del	p.Met1fs	frameshift_variant&start_lost				35	0.0
	MYL1(12.0%)	exon1,c.1del,p.M1fs	0.12	0.115	974|194	260|40	0.14245	2384|396	2	211179765	211179768	ATTT	ATT	multiallelic,suspected_bg	MYL1	NM_079420.3	1	c.1del	p.Met1fs	frameshift_variant&start_lost				38	0.0
	MYL1(3.2%)	exon1,c.1dup,p.M1fs	0.032	0.025	974|62	260|8	0.06289	2384|160	2	211179765	211179768	ATTT	ATTTT	multiallelic,suspected_bg	MYL1	NM_079420.3	1	c.1dup	p.Met1fs	start_retained_variant	Benign		not_provided	41	0.0
	UGT1A1(1.8%)	exon,c.-55_-54insAT	0.018	0.019	4187|97	2649|62	0.02040	27322|569	2	234668879	234668883	CATAT	CATATAT	clustered_events,multiallelic,normal_artifact,background	UGT1A1	NM_000463.3		c.-55_-54insAT		upstream_gene_variant	Conflicting_interpretations_of_pathogenicity|_drug_response|_other	Pathogenic(5)|_Benign(4)	Gilbert_syndrome|Lucey-Driscoll_syndrome|Crigler-Najjar_syndrome,_type_II|Crigler-Najjar_syndrome_type_1|Bilirubin,_serum_level_of,_quantitative_trait_locus_1|Irinotecan_response|not_specified|not_provided	39	0.0
2	FANCD2(8.2%)	exon6,c.378-5del	0.082	0.116	476|51	131|20	0.07243	730|57	3	10076842	10076843	CT	C	multiallelic,normal_artifact,slippage,suspected_bg	FANCD2	NM_033084.6	5	c.378-5del		splice_region_variant&intron_variant				44	0.0
2	FANCD2(7.1%)	exon6,c.378-5dup	0.071	0.074	476|47	131|12	0.08750	730|70	3	10076842	10076843	CT	CTT	multiallelic,normal_artifact,slippage,distinguished	FANCD2	NM_033084.6	5	c.378-5dup		splice_region_variant&intron_variant				44	0.0
	TGFBR2(43.2%)	exon4,c.458del,p.K153fs	0.432	0.065	449|372	181|16	0.45576	818|685	3	30691871	30691873	GAA	GA	multiallelic,normal_artifact,distinguished	TGFBR2	NM_001024847.2	4	c.458del	p.Lys153fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Benign(3)|_Likely_benign(1)	Loeys-Dietz_syndrome|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified|Cardiovascular_phenotype|not_provided	41	0.0
-	MLH1(36.6%)	exon16,c.1882_1883del,p.L628fs	0.366	0.00323	932|531	387|0	0.35840	1647|920	3	37089158	37089160	CTT	C	PASS	MLH1	NM_000249.4	16	c.1882_1883del	p.Leu628fs	frameshift_variant	Pathogenic		Lynch_syndrome|Hereditary_cancer-predisposing_syndrome	45	0.0
	MYD88(11.5%)	exon2,c.397G>A,p.A133T	0.115	0.1	32|4	12|0	0.09756	37|4	3	38181423	38181423	G	A	PASS	MYD88	NM_002468.5	2	c.397G>A	p.Ala133Thr	missense_variant				27	0.0
	CTNNB1(36.6%)	exon3,c.120_121delinsAG,p.T41A	0.366	0.003482	1638|916	568|1	0.35800	4026|2245	3	41266123	41266124	TA	AG	PASS	CTNNB1	NM_001904.4	3	c.120_121delinsAG	p.Thr41Ala	missense_variant				40	0.0
	ANO10(5.8%)	exon2,c.132del,p.D45fs	0.058	0.062	3282|234	1289|90	0.04913	12405|641	3	43647212	43647213	CT	C	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic		not_provided	46	0.0
	ANO10(1.8%)	exon2,c.132dup,p.D45fs	0.018	0.033	3282|92	1289|54	0.03538	12405|455	3	43647212	43647213	CT	CTT	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132dup	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Abnormal_central_motor_function|Spinocerebellar_ataxia,_autosomal_recessive_10|Autosomal_recessive_cerebellar_ataxia|not_provided	49	0.0
	RBM5(1.4%)	exon25,c.2448A>T,p.*816Cext*?	0.014	0.013	1102|22	209|6	0.20417	1754|450	3	50155889	50155889	A	T	background	RBM5	NM_005778.4	25	c.2448A>T	p.Ter816Cysext*?	stop_lost				36	0.0
	PIK3CB(2.5%)	exon14,c.1775A>G,p.Q592R	0.025	0.023	264|8	52|0	0.02222	352|8	3	138413745	138413745	T	C	PASS	PIK3CB	NM_006219.3	14	c.1775A>G	p.Gln592Arg	missense_variant				30	0.0
	ATR(9.5%)	exon10,c.2320del,p.I774fs	0.095	0.07	3758|457	1666|145	0.07325	13221|1045	3	142274739	142274740	AT	A	multiallelic,normal_artifact,slippage,background	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrial_neoplasm|not_provided	43	0.0
	ATR(1.8%)	exon10,c.2320dup,p.I774fs	0.018	0.032	3758|104	1666|76	0.04189	13221|578	3	142274739	142274740	AT	ATT	multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic		not_provided	38	0.0
	PIK3CA(18.7%)	exon5,c.1037T>A,p.V346E	0.187	0.001323	1816|417	939|0	0.18458	4431|1003	3	178921555	178921555	T	A	PASS	PIK3CA	NM_006218.4	5	c.1037T>A	p.Val346Glu	missense_variant				37	0.0
1	PIK3CA(0.1%)	exon10,c.1624G>A,p.E542K	0.0008557	0.0008117	4189|3	1577|1	0.00078	14133|11	3	178936082	178936082	G	A	clustered_events,orientation,strand_bias,weak_evidence,background	PIK3CA	NM_006218.4	10	c.1624G>A	p.Glu542Lys	missense_variant	Pathogenic		CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Carcinoma_of_esophagus|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Adenocarcinoma_of_prostate|Squamous_cell_carcinoma_of_the_head_and_neck|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Glioblastoma|Lip_and_oral_cavity_carcinoma|Overgrowth_syndrome_and/or_cerebral_malformations_due_to_abnormalities_in_MTOR_pathway_genes|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus|not_provided	55	0.0
1	PIK3CA(0.1%)	exon10,c.1634A>C,p.E545A	0.0006166	0.0008201	4045|3	1530|1	0.00124	13672|17	3	178936092	178936092	A	C	clustered_events,orientation,strand_bias,weak_evidence	PIK3CA	NM_006218.4	10	c.1634A>C	p.Glu545Ala	missense_variant	Pathogenic		Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Carcinoma_of_gallbladder|Adenocarcinoma_of_prostate|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus	21	0.0
1	PIK3CA(0.1%)	exon10,c.1634A>T,p.E545V	0.0006544	0.001411	4045|3	1530|1	0.00095	13672|13	3	178936092	178936092	A	T	clustered_events,orientation,strand_bias,weak_evidence	PIK3CA	NM_006218.4	10	c.1634A>T	p.Glu545Val	missense_variant	Pathogenic		Breast_neoplasm|Neoplasm_of_the_large_intestine	55	0.0
1	PIK3CA(0.1%)	exon21,c.3139C>T,p.H1047Y	0.0005765	0.0004247	5533|6	2915|0	0.00090	29009|26	3	178952084	178952085	C	T	clustered_events,weak_evidence	PIK3CA	NM_006218.4	21	c.3139C>T	p.His1047Tyr	missense_variant	Pathogenic		Segmental_undergrowth_associated_with_mainly_venous_malformation_with_capillary_component|Hepatocellular_carcinoma|Medulloblastoma|Adrenocortical_carcinoma|Congenital_macrodactylia|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_stomach|Breast_neoplasm|Brainstem_glioma|Epidermal_nevus|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Seborrheic_keratosis|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Adenocarcinoma_of_prostate|Lung_carcinoma|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Cowden_syndrome_5|Cowden_syndrome|Familial_cancer_of_breast|Glioblastoma|Malignant_tumor_of_floor_of_mouth|Malignant_neoplasm_of_body_of_uterus|not_provided	51	0.0
1	KIT(0.0%)	exon11,c.1669T>A,p.W557R	0.0003644	0.0003697	5997|5	3364|7	0.00248	30161|75	4	55593603	55593603	T	A	base_qual,clustered_events,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1669T>A	p.Trp557Arg	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stroma_tumor	53	0.0
1	KIT(0.0%)	exon11,c.1676T>C,p.V559A	0.0004453	0.0007309	5980|3	3323|4	0.00071	29645|21	4	55593610	55593610	T	C	clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1676T>C	p.Val559Ala	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Thymoma|Gastrointestinal_stroma_tumor|Cutaneous_mastocytosis|Gastrointestinal_stromal_tumor,_familial	27	0.0
1	KIT(0.0%)	exon11,c.1676T>G,p.V559G	0.0002798	0.0004138	5980|6	3323|10	0.00360	29645|107	4	55593610	55593610	T	G	clustered_events,orientation,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1676T>G	p.Val559Gly	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stroma_tumor	50	0.0
	KIT(15.8%)	exon19,c.2621C>T,p.P874L	0.158	0.003796	863|160	293|0	0.16083	1534|294	4	55602911	55602911	C	T	PASS	KIT	NM_000222.3	19	c.2621C>T	p.Pro874Leu	missense_variant	Uncertain_significance		Gastrointestinal_stroma_tumor|Hereditary_cancer-predisposing_syndrome	29	0.0
	TET2(21.2%)	exon3,c.286C>T,p.R96C	0.212	0.018	196|53	55|0	0.20728	283|74	4	106155385	106155385	C	T	PASS	TET2	NM_001127208.3	3	c.286C>T	p.Arg96Cys	missense_variant				37	0.0
	FAT1(1.8%)	exon25,c.12938del,p.P4313fs	0.018	0.003179	1084|23	398|0	0.01355	1966|27	4	187517755	187517756	AG	A	PASS	FAT1	NM_005245.4	25	c.12938del	p.Pro4313fs	frameshift_variant				33	0.0
	RICTOR(16.1%)	exon7,c.568A>G,p.I190V	0.161	0.004017	834|165	295|0	0.16268	1925|374	5	38991066	38991066	T	C	PASS	RICTOR	NM_152756.5	7	c.568A>G	p.Ile190Val	missense_variant				34	0.0
	MSH3(2.0%)	exon7,c.1148del,p.K383fs	0.02	0.022	4074|102	1863|54	0.02429	14181|353	5	79970914	79970915	CA	C	multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic		Endometrial_carcinoma|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_4|not_provided	35	0.0
	MSH3(1.4%)	exon7,c.1148dup,p.N385fs	0.014	0.016	4074|87	1863|47	0.02536	14181|369	5	79970914	79970915	CA	CAA	multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic		not_provided	35	0.0
	MSH3(0.5%)	exon7,c.1149G>A,p.K383=	0.004549	0.002323	4408|24	2028|4	0.00539	14943|81	5	79970923	79970923	G	A	low_allele_frac	MSH3	NM_002439.5	7	c.1149G>A	p.Lys383=	synonymous_variant	Likely_benign		not_provided	39	0.0
-	APC(2.4%)	exon5,c.423-5_423-4del	0.024	0.075	212|10	60|4	0.03325	407|14	5	112111309	112111311	TAA	T	multiallelic,normal_artifact	APC	NM_000038.6	4	c.423-5_423-4del		splice_region_variant&intron_variant				49	0.0
-	APC(22.0%)	exon5,c.423-4del	0.22	0.153	212|70	60|13	0.21124	407|109	5	112111309	112111311	TAA	TA	multiallelic,normal_artifact,distinguished	APC	NM_000038.6	4	c.423-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Malignant_Colorectal_Neoplasm|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|not_specified|not_provided	37	0.0
-	APC(11.0%)	exon5,c.423-4dup	0.11	0.062	212|46	60|5	0.15735	407|76	5	112111309	112111311	TAA	TAAA	multiallelic,normal_artifact,suspected_bg	APC	NM_000038.6	4	c.423-4dup		splice_region_variant&intron_variant	Benign		Familial_adenomatous_polyposis_1|not_specified	38	0.0
	RAD50(19.9%)	exon13,c.2164_2165del,p.K722fs	0.199	0.002921	2987|799	1678|5	0.18541	13343|3037	5	131931451	131931453	TAA	T	multiallelic	RAD50	NM_005732.4	13	c.2164_2165del	p.Lys722fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome	44	0.0
	RAD50(5.3%)	exon13,c.2165del,p.K722fs	0.053	0.054	2987|233	1678|119	0.05796	13343|821	5	131931451	131931453	TAA	TA	multiallelic,suspected_bg	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome	47	0.0
	RAD50(1.3%)	exon13,c.2165dup,p.E723fs	0.013	0.024	2987|77	1678|56	0.03157	13343|435	5	131931451	131931453	TAA	TAAA	multiallelic,suspected_bg	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided	40	0.0
	NSD1(2.1%)	exon5,c.2903A>G,p.K968R	0.021	0.013	292|6	92|0	0.01869	420|8	5	176638303	176638303	A	G	distinguished	NSD1	NM_022455.5	5	c.2903A>G	p.Lys968Arg	missense_variant				54	0.0
	FANCE(2.6%)	exon4,c.929del,p.P310fs	0.026	0.026	454|12	84|2	0.01967	648|13	6	35425714	35425715	GC	G	background	FANCE	NM_021922.3	4	c.929del	p.Pro310fs	frameshift_variant	not_provided		not_specified	32	0.0
	CEP162(0.2%)	exon12,c.1159C>T,p.P387S	0.001863	0.0007589	4979|10	1734|0	0.00152	19032|29	6	84896292	84896292	G	A	low_allele_frac	CEP162	NM_014895.4	12	c.1159C>T	p.Pro387Ser	missense_variant				24	0.0
	EGFR(18.9%)	exon12,c.1305G>A,p.Q435=	0.189	0.0006201	7331|1725	5456|3	0.18705	43504|10010	7	55227838	55227838	G	A	PASS	EGFR	NM_005228.5	12	c.1305G>A	p.Gln435=	synonymous_variant				40	0.0
1	EGFR(0.2%)	exon18,c.2155G>T,p.G719C	0.00216	0.001302	1754|3	883|0	0.00105	4768|5	7	55241707	55241707	G	T	clustered_events,orientation,weak_evidence	EGFR	NM_005228.5	18	c.2155G>T	p.Gly719Cys	missense_variant	Pathogenic/Likely_pathogenic|_drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Glioblastoma|Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic	15	0.0
1	EGFR(0.4%)	exon20,c.2387G>A,p.G796D	0.003824	0.002226	1802|7	1069|1	0.00166	4202|7	7	55249089	55249089	G	A	clustered_events	EGFR	NM_005228.5	20	c.2387G>A	p.Gly796Asp	missense_variant	Uncertain_significance		EGFR-related_lung_cancer	40	0.0
	THAP5(19.0%)	exon3,c.320A>G,p.D107G	0.19	0.0003701	5471|1287	3575|0	0.17950	24875|5442	7	108205503	108205503	T	C	PASS	THAP5	NM_001130475.3	3	c.320A>G	p.Asp107Gly	missense_variant				41	0.0
1	MET(0.0%)	exon14,c.3008A>T,p.Y1003F	0.0002925	0.0003121	7408|3	4111|1	0.00163	51336|84	7	116412023	116412023	A	T	clustered_events,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3008A>T	p.Tyr1003Phe	missense_variant				25	0.0
1	MET(0.1%)	exon14,c.3028G>A,p.D1010N	0.0007399	0.001054	7479|5	4130|3	0.00049	50831|25	7	116412043	116412043	G	A	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>A	p.Asp1010Asn	missense_variant&splice_region_variant	Pathogenic		Lung_carcinoma	18	0.0
1	MET(0.0%)	exon14,c.3028G>C,p.D1010H	0.0002854	0.0003135	7479|4	4130|6	0.00065	50831|33	7	116412043	116412043	G	C	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>C	p.Asp1010His	missense_variant&splice_region_variant				31	0.0
1	MET(0.0%)	exon14,c.3028G>T,p.D1010Y	0.0001841	0.0003129	7479|4	4130|6	0.00398	50831|203	7	116412043	116412043	G	T	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>T	p.Asp1010Tyr	missense_variant&splice_region_variant				27	0.0
1	MET(0.1%)	exon14,c.3028+1G>A	0.0005765	0.0003099	7473|4	4149|0	0.00094	50910|48	7	116412044	116412044	G	A	clustered_events,orientation,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028+1G>A		splice_donor_variant&intron_variant	not_provided		not_provided	50	0.0
	BRAF(0.0%)	exon15,c.1802A>T,p.K601I	0.0004948	0.001635	5485|3	2147|4	0.00229	25737|59	7	140453133	140453133	T	A	clustered_events,normal_artifact,orientation,weak_evidence,low_allele_frac	BRAF	NM_004333.6	15	c.1802A>T	p.Lys601Ile	missense_variant	Pathogenic		Cardiofaciocutaneous_syndrome_1|Cardio-facio-cutaneous_syndrome|Rasopathy|not_provided	17	0.0
1	BRAF(0.1%)	exon15,c.1801A>G,p.K601E	0.0005854	0.0006013	5472|3	2147|0	0.00047	25745|12	7	140453134	140453134	T	C	base_qual,clustered_events,weak_evidence	BRAF	NM_004333.6	15	c.1801A>G	p.Lys601Glu	missense_variant	Pathogenic		Neoplasm|Melanoma|B-cell_chronic_lymphocytic_leukemia|Thyroid_cancer,_nonmedullary,_2|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_thyroid_gland|Carcinoma_of_colon|Adenocarcinoma_of_prostate|Malignant_neoplasm_of_body_of_uterus	19	0.0
	BRAF(0.0%)	exon15,c.1799T>C,p.V600A	0.0004938	0.0005965	5412|3	2140|0	0.00040	25288|10	7	140453136	140453137	A	G	clustered_events,orientation,weak_evidence,low_allele_frac	BRAF	NM_004333.6	15	c.1799T>C	p.Val600Ala	missense_variant	Likely_pathogenic		Melanoma	22	0.0
1	BRAF(0.0%)	exon15,c.1799T>A,p.V600E	0.0002503	0.0006698	5412|4	2140|1	0.00300	25288|76	7	140453136	140453137	A	T	clustered_events,orientation,weak_evidence	BRAF	NM_004333.6	15	c.1799T>A	p.Val600Glu	missense_variant	Pathogenic|_drug_response|_other		Cystic_epithelial_invagination_containing_papillae_lined_by_columnar_epithelium|See_cases|Trametinib-Dabrafenib_Response|Vemurafenib-Cobimetinib_Response|Nephroblastoma|Cerebral_arteriovenous_malformation|Neoplasm|Melanoma|Papillary_thyroid_carcinoma|Multiple_myeloma|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Colonic_neoplasm|Neoplasm_of_ovary|Gastrointestinal_stroma_tumor|Lymphangioma|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Malignant_neoplastic_disease|Lung_carcinoma|Malignant_Colorectal_Neoplasm|Squamous_cell_carcinoma_of_the_head_and_neck|Cardio-facio-cutaneous_syndrome|Glioblastoma|Germ_cell_tumor,_nonseminomatous|Papillary_renal_cell_carcinoma,_sporadic|Astrocytoma,_low-grade,_somatic|not_provided	13	0.0
1	BRAF(0.1%)	exon15,c.1798G>A,p.V600M	0.0006716	0.001625	5414|3	2137|2	0.00055	25407|14	7	140453137	140453137	C	T	clustered_events,orientation,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1798G>A	p.Val600Met	missense_variant	Likely_pathogenic		Melanoma|Non-small_cell_lung_carcinoma|not_provided	34	0.0
	BRAF(0.1%)	exon15,c.1796C>T,p.T599I	0.0007602	0.001212	5366|4	2120|2	0.00044	25204|11	7	140453139	140453139	G	A	clustered_events,orientation,strand_bias,weak_evidence,low_allele_frac	BRAF	NM_004333.6	15	c.1796C>T	p.Thr599Ile	missense_variant	Pathogenic		Neoplasm|Melanoma|Cardiofaciocutaneous_syndrome_1|Noonan_syndrome|Rasopathy|not_provided	32	0.0
-	KMT2C(2.0%)	exon38,c.8390dup,p.E2798fs	0.02	0.033	6197|170	3661|165	0.03914	31151|1269	7	151874147	151874148	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided	37	0.0
	KMT2C(5.6%)	exon18,c.2895T>C,p.S965=	0.056	0.022	298|15	58|0	0.04847	373|19	7	151927089	151927089	A	G	orientation,background	KMT2C	NM_170606.3	18	c.2895T>C	p.Ser965=	synonymous_variant	Likely_benign		not_provided	44	0.0
	KMT2C(1.3%)	exon14,c.2437C>T,p.P813S	0.013	0.00368	1501|23	342|1	0.01493	2244|34	7	151945082	151945082	G	A	PASS	KMT2C	NM_170606.3	14	c.2437C>T	p.Pro813Ser	missense_variant				39	0.0
	KMT2C(4.2%)	exon8,c.1139G>T,p.R380L	0.042	0.022	453|22	122|2	0.04748	642|32	7	151962168	151962168	C	A	clustered_events,background	KMT2C	NM_170606.3	8	c.1139G>T	p.Arg380Leu	missense_variant	Benign/Likely_benign		not_specified|not_provided	46	0.0
	KMT2C(3.5%)	exon8,c.1038G>A,p.V346=	0.035	0.012	439|13	118|0	0.03511	632|23	7	151962269	151962269	C	T	clustered_events,orientation,background	KMT2C	NM_170606.3	8	c.1038G>A	p.Val346=	synonymous_variant	Likely_benign		not_provided	36	0.0
-	KMT2C(3.2%)	exon8,c.1013-2_1013delinsGGT,p.S338L	0.032	0.013	343|8	91|0	0.03219	451|15	7	151962294	151962296	GCT	ACC	clustered_events	KMT2C	NM_170606.3	8	c.1013-2_1013delinsGGT	p.Ser338Leu	splice_acceptor_variant&missense_variant&splice_region_variant&intron_variant				16	0.0
	GOT1L1(42.0%)	exon9,c.1243del,p.T415fs	0.42	0.018	2522|1932	1375|31	0.40067	9488|6343	8	37791833	37791834	GT	G	multiallelic,distinguished	GOT1L1	NM_152413.3	9	c.1243del	p.Thr415fs	frameshift_variant				38	0.0
	KAT6A(8.7%)	exon15,c.2977_2979del,p.E993del	0.087	0.059	71|4	19|0	0.04167	92|4	8	41798419	41798422	GCTC	G	slippage,distinguished	KAT6A	NM_006766.5	15	c.2977_2979del	p.Glu993del	conservative_inframe_deletion	Conflicting_interpretations_of_pathogenicity	Uncertain_significance(1)|_Likely_benign(1)	not_provided	32	0.0
	PRKDC(18.3%)	exon44,c.5836T>C,p.C1946R	0.183	0.042	141|29	31|0	0.15068	186|33	8	48775014	48775014	A	G	PASS	PRKDC	NM_006904.7	44	c.5836T>C	p.Cys1946Arg	missense_variant				34	0.0
	PRKDC(19.5%)	exon35,c.4314T>C,p.P1438=	0.195	0.023	195|49	55|0	0.21036	244|65	8	48801175	48801175	A	G	PASS	PRKDC	NM_006904.7	35	c.4314T>C	p.Pro1438=	synonymous_variant				46	0.0
	NBN(0.4%)	exon11,c.1651del,p.R551fs	0.00436	0.006047	5543|54	3200|28	0.00563	28260|160	8	90965665	90965666	CT	C	normal_artifact,low_allele_frac	NBN	NM_002485.5	11	c.1651del	p.Arg551fs	frameshift_variant	Pathogenic		Microcephaly	43	0.0
	MYC(24.3%)	exon2,c.176C>T,p.A59V	0.243	0.051	59|19	40|1	0.21649	76|21	8	128750639	128750639	C	T	normal_artifact	MYC	NM_002467.6	2	c.176C>T	p.Ala59Val	missense_variant	Likely_pathogenic		Neoplasm	26	0.0
-	CDKN2A(14.2%)	exon2,c.269dup,p.L91fs	0.142	0.013	90|15	79|0	0.12329	128|18	9	21971088	21971088	G	GA	PASS	CDKN2A	NM_000077.5	2	c.269dup	p.Leu91fs	frameshift_variant				21	0.0
1	RET(0.0%)	exon16,c.2753T>C,p.M918T	0.0002994	0.0003171	9480|3	4241|0	0.00009	43900|4	10	43617416	43617416	T	C	orientation,strand_bias,weak_evidence	RET	NM_020975.6	16	c.2753T>C	p.Met918Thr	missense_variant	Pathogenic/Likely_pathogenic		Gingival_overgrowth|Hypertelorism|Hypothyroidism|Joint_hypermobility|Short_stature|Tetralogy_of_Fallot|Constipation|Pheochromocytoma|Medullary_thyroid_carcinoma|Thick_vermilion_border|Neoplasm_of_the_thyroid_gland|Multiple_endocrine_neoplasia,_type_1|Hirschsprung_disease_1|Familial_medullary_thyroid_carcinoma|Multiple_endocrine_neoplasia,_type_2b|Multiple_endocrine_neoplasia,_type_2a|Multiple_endocrine_neoplasia,_type_4|Multiple_endocrine_neoplasia,_type_2|Inborn_genetic_diseases|Thyroid_carcinoma,_sporadic_medullary|not_specified|not_provided	51	0.0
	TFAM(20.7%)	exon4,c.440_441del,p.K147fs	0.207	0.008719	1239|400	501|6	0.19544	3108|755	10	60148569	60148571	CAA	C	multiallelic	TFAM	NM_003201.3	4	c.440_441del	p.Lys147fs	frameshift_variant&splice_region_variant				46	0.0
	TFAM(8.1%)	exon4,c.441del,p.E148fs	0.081	0.066	1239|165	501|42	0.09123	3108|312	10	60148569	60148571	CAA	CA	multiallelic,suspected_bg	TFAM	NM_003201.3	4	c.441del	p.Glu148fs	frameshift_variant&splice_region_variant				47	0.0
	TFAM(2.9%)	exon4,c.441dup	0.029	0.04	1239|76	501|22	0.07279	3108|244	10	60148569	60148571	CAA	CAAA	multiallelic,suspected_bg	TFAM	NM_003201.3	4	c.441dup		splice_donor_variant&intron_variant				45	0.0
-	PTEN(4.8%)	exon8,c.802-7_802-3del	0.048	0.00744	168|38	52|0	0.04939	1097|57	10	89720633	89720638	CTTTTT	C	multiallelic,normal_artifact	PTEN	NM_000314.8	7	c.802-7_802-3del		splice_region_variant&intron_variant				26	0.0
-	PTEN(17.8%)	exon8,c.802-6_802-3del	0.178	0.016	168|142	52|2	0.21306	1097|297	10	89720633	89720638	CTTTTT	CT	multiallelic,normal_artifact	PTEN	NM_000314.8	7	c.802-6_802-3del		splice_region_variant&intron_variant				36	0.0
-	PTEN(17.2%)	exon8,c.802-5_802-3del	0.172	0.034	168|131	52|3	0.23394	1097|335	10	89720633	89720638	CTTTTT	CTT	multiallelic,normal_artifact	PTEN	NM_000314.8	7	c.802-5_802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|PTEN_hamartoma_tumor_syndrome	33	0.0
-	PTEN(11.6%)	exon8,c.802-4_802-3del	0.116	0.048	168|92	52|8	0.19693	1097|269	10	89720633	89720638	CTTTTT	CTTT	multiallelic,normal_artifact	PTEN	NM_000314.8	7	c.802-4_802-3del		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	36	0.0
-	PTEN(17.9%)	exon8,c.802-3del	0.179	0.153	168|126	52|21	0.28254	1097|432	10	89720633	89720638	CTTTTT	CTTTT	multiallelic,normal_artifact,Germline	PTEN	NM_000314.8	7	c.802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|PTEN_hamartoma_tumor_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided	40	0.0
-	PTEN(3.0%)	exon8,c.802-3dup	0.03	0.106	168|27	52|14	0.08811	1097|106	10	89720633	89720638	CTTTTT	CTTTTTT	multiallelic,normal_artifact,suspected_bg	PTEN	NM_000314.8	7	c.802-3dup		splice_acceptor_variant&intron_variant	Benign		PTEN_hamartoma_tumor_syndrome|not_specified|not_provided	34	0.0
-	ATM(15.4%)	exon6,c.497-5_497-4del	0.154	0.033	126|48	39|1	0.14945	387|68	11	108114661	108114663	ATT	A	multiallelic,normal_artifact	ATM	NM_000051.4	5	c.497-5_497-4del		splice_region_variant&intron_variant				37	0.0
-	ATM(29.9%)	exon6,c.497-4del	0.299	0.146	126|89	39|9	0.31986	387|182	11	108114661	108114663	ATT	AT	multiallelic,normal_artifact,distinguished	ATM	NM_000051.4	5	c.497-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_specified|not_provided	36	0.0
-	ATM(8.1%)	exon6,c.497-4dup	0.081	0.083	126|26	39|5	0.12443	387|55	11	108114661	108114663	ATT	ATTT	multiallelic,normal_artifact,suspected_bg	ATM	NM_000051.4	5	c.497-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	46	0.0
-	ATM(2.5%)	exon6,c.497-5_497-4dup	0.025	0.034	126|6	39|1	0.03008	387|12	11	108114661	108114663	ATT	ATTTT	multiallelic,normal_artifact	ATM	NM_000051.4	5	c.497-5_497-4dup		splice_region_variant&intron_variant				44	0.0
-	ATM(10.5%)	exon10,c.1236-8_1236-3del	0.105	0.028	44|25	9|0	0.10222	202|23	11	108121410	108121416	CTTTTTT	C	multiallelic	ATM	NM_000051.4	9	c.1236-8_1236-3del		splice_region_variant&intron_variant				24	0.0
-	ATM(22.6%)	exon10,c.1236-7_1236-3del	0.226	0.029	44|55	9|0	0.26545	202|73	11	108121410	108121416	CTTTTTT	CT	multiallelic	ATM	NM_000051.4	9	c.1236-7_1236-3del		splice_region_variant&intron_variant				46	0.0
-	ATM(7.6%)	exon10,c.1236-6_1236-3del	0.076	0.029	44|18	9|0	0.12931	202|30	11	108121410	108121416	CTTTTTT	CTT	multiallelic	ATM	NM_000051.4	9	c.1236-6_1236-3del		splice_region_variant&intron_variant				43	0.0
-	ATM(8.1%)	exon10,c.1236-5_1236-3del	0.081	0.067	44|18	9|1	0.19200	202|48	11	108121410	108121416	CTTTTTT	CTTT	multiallelic	ATM	NM_000051.4	9	c.1236-5_1236-3del		splice_region_variant&intron_variant				39	0.0
-	ATM(9.4%)	exon10,c.1236-4_1236-3del	0.094	0.101	44|22	9|2	0.14768	202|35	11	108121410	108121416	CTTTTTT	CTTTT	multiallelic	ATM	NM_000051.4	9	c.1236-4_1236-3del		splice_region_variant&intron_variant	Benign		Breast_and/or_ovarian_cancer|not_provided	32	0.0
-	ATM(6.7%)	exon10,c.1236-3del	0.067	0.158	44|13	9|4	0.14043	202|33	11	108121410	108121416	CTTTTTT	CTTTTT	multiallelic,suspected_bg	ATM	NM_000051.4	9	c.1236-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided	42	0.0
-	ATM(7.9%)	exon10,c.1236-3dup	0.079	0.208	44|18	9|5	0.15481	202|37	11	108121410	108121416	CTTTTTT	CTTTTTTT	multiallelic,suspected_bg	ATM	NM_000051.4	9	c.1236-3dup		splice_acceptor_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided	36	0.0
	CEP164(6.8%)	exon5,c.346_347del,p.K116fs	0.068	0.021	220|40	89|1	0.12723	391|57	11	117222647	117222649	GAA	G	multiallelic	CEP164	NM_014956.5	5	c.346_347del	p.Lys116fs	frameshift_variant				36	0.0
	CEP164(48.4%)	exon5,c.347del,p.K116fs	0.484	0.046	220|268	89|5	0.51609	391|417	11	117222647	117222649	GAA	GA	multiallelic,Germline	CEP164	NM_014956.5	5	c.347del	p.Lys116fs	frameshift_variant	Benign		Nephronophthisis_15|not_provided	42	0.0
	CEP164(2.2%)	exon5,c.347dup,p.E117fs	0.022	0.106	220|17	89|14	0.08216	391|35	11	117222647	117222649	GAA	GAAA	multiallelic,suspected_bg	CEP164	NM_014956.5	5	c.347dup	p.Glu117fs	frameshift_variant				46	0.0
	CD3G(7.2%)	exon3,c.213del,p.K71fs	0.072	0.049	2015|168	663|36	0.07220	4626|360	11	118220582	118220583	TA	T	multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Uncertain_significance(1)	Immunodeficiency_17	45	0.0
	CD3G(1.7%)	exon3,c.213dup,p.W72fs	0.017	0.03	2015|39	663|23	0.02157	4626|102	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic		Immunodeficiency_17	45	0.0
	KMT2A(2.6%)	exon3,c.2318del,p.P773fs	0.026	0.022	5026|180	1630|50	0.01896	16867|326	11	118344185	118344186	AC	A	normal_artifact,distinguished	KMT2A	NM_001197104.2	3	c.2318del	p.Pro773fs	frameshift_variant	Pathogenic		Inborn_genetic_diseases	39	0.0
	KDM5A(2.4%)	exon23,c.3597del,p.G1200fs	0.024	0.047	1001|33	176|8	0.02849	1637|48	12	416952	416953	CT	C	multiallelic,slippage,suspected_bg	KDM5A	NM_001042603.3	23	c.3597del	p.Gly1200fs	frameshift_variant				44	0.0
	KDM5A(3.0%)	exon23,c.3597dup,p.G1200fs	0.03	0.012	1001|43	176|3	0.03365	1637|57	12	416952	416953	CT	CTT	multiallelic,slippage,suspected_bg	KDM5A	NM_001042603.3	23	c.3597dup	p.Gly1200fs	frameshift_variant				34	0.0
	CHD4(9.0%)	exon4,c.355_357del,p.K119del	0.09	0.12	45|3	6|0	0.04839	59|3	12	6711206	6711209	GCTT	G	slippage,distinguished	CHD4	NM_001273.5	4	c.355_357del	p.Lys119del	conservative_inframe_deletion				23	0.0
	CHD4(3.6%)	exon3,c.218del,p.K73fs	0.036	0.041	134|5	21|0	0.02924	166|5	12	6711545	6711546	CT	C	distinguished	CHD4	NM_001273.5	3	c.218del	p.Lys73fs	frameshift_variant				47	0.0
1	KRAS(0.1%)	exon4,c.437C>T,p.A146V	0.001021	0.000421	4707|4	3206|0	0.00045	26437|12	12	25378561	25378562	G	A	orientation,weak_evidence	KRAS	NM_033360.4	4	c.437C>T	p.Ala146Val	missense_variant	Pathogenic		OCULOECTODERMAL_SYNDROME,_SOMATIC|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine|Encephalocraniocutaneous_lipomatosis	57	0.0
1	KRAS(0.1%)	exon4,c.436G>A,p.A146T	0.0008761	0.0006022	4740|3	3223|1	0.00052	26672|14	12	25378562	25378562	C	T	orientation,weak_evidence	KRAS	NM_033360.4	4	c.436G>A	p.Ala146Thr	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Uncertain_significance(1)	OCULOECTODERMAL_SYNDROME,_SOMATIC|Neoplasm_of_the_large_intestine|Encephalocraniocutaneous_lipomatosis|Rasopathy|not_provided	44	0.0
1	KRAS(0.0%)	exon3,c.182A>T,p.Q61L	0.000309	0.0003821	5182|3	3540|1	0.00153	28804|44	12	25380276	25380277	T	A	clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	3	c.182A>T	p.Gln61Leu	missense_variant	Pathogenic		Medullary_thyroid_carcinoma|Multiple_myeloma|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	20	0.0
1	KRAS(0.1%)	exon3,c.182A>G,p.Q61R	0.0008469	0.000382	5182|4	3540|0	0.00031	28804|9	12	25380276	25380277	T	C	clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	3	c.182A>G	p.Gln61Arg	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Uncertain_significance(2)	Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine|Noonan_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|Rasopathy	45	0.0
1	KRAS(0.1%)	exon3,c.175G>T,p.A59S	0.001166	0.001502	4999|4	3382|7	0.00116	27664|32	12	25380283	25380283	C	A	clustered_events,normal_artifact,orientation,weak_evidence	KRAS	NM_033360.4	3	c.175G>T	p.Ala59Ser	missense_variant	Pathogenic/Likely_pathogenic		not_provided	19	0.0
1	KRAS(17.7%)	exon2,c.35G>A,p.G12D	0.177	0.0007675	4623|978	3894|2	0.16827	22687|4590	12	25398284	25398285	C	T	clustered_events	KRAS	NM_033360.4	2	c.35G>A	p.Gly12Asp	missense_variant	Pathogenic		Vascular_Tumors_Including_Pyogenic_Granuloma|Acute_myeloid_leukemia|Cerebral_arteriovenous_malformation|Neoplasm_of_stomach|Nevus_sebaceous|Epidermal_nevus|Linear_sebaceous_nevus_sequence|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Lung_carcinoma|Carcinoma_of_pancreas|Encephalocraniocutaneous_lipomatosis|RAS-associated_autoimmune_leukoproliferative_disorder|Capillary_malformation-arteriovenous_malformation_1|Rasopathy|Primary_low_grade_serous_adenocarcinoma_of_ovary|not_provided	38	0.0
1	KRAS(0.1%)	exon2,c.34_35delinsAA,p.G12N	0.0006291	0.0003258	4623|3	3894|0	0.00018	22687|4	12	25398284	25398285	CC	TT	clustered_events	KRAS	NM_033360.4	2	c.34_35delinsAA	p.Gly12Asn	missense_variant				19	0.0
1	KRAS(0.1%)	exon2,c.34G>A,p.G12S	0.0007355	0.0003278	5605|5	3901|0	0.00102	27394|28	12	25398285	25398285	C	T	clustered_events,orientation,weak_evidence	KRAS	NM_033360.4	2	c.34G>A	p.Gly12Ser	missense_variant	Pathogenic		Stomach_cancer|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Rasopathy|not_provided	31	0.0
	KMT2D(61.4%)	exon40,c.10836G>A,p.Q3612=	0.614	0.143	8|17	5|0	0.68966	9|20	12	49427652	49427652	C	T	germline,Germline	KMT2D	NM_003482.4	40	c.10836G>A	p.Gln3612=	synonymous_variant	Benign		Kabuki_syndrome_1|Kabuki_syndrome|not_specified|not_provided	36	0.0
-	KMT2D(17.9%)	exon29,c.6040C>T,p.Q2014*	0.179	0.033	90|17	35|0	0.14729	110|19	12	49435941	49435941	G	A	PASS	KMT2D	NM_003482.4	29	c.6040C>T	p.Gln2014*	stop_gained	Likely_pathogenic		Rubinstein_taybi_like_syndrome	44	0.0
-	KMT2D(0.7%)	exon11,c.2317del,p.Q773fs	0.007339	0.007568	3138|37	2669|26	0.00906	22540|206	12	49445148	49445149	TG	T	clustered_events,normal_artifact,low_allele_frac	KMT2D	NM_003482.4	11	c.2317del	p.Gln773fs	frameshift_variant	Likely_pathogenic		not_provided	41	0.0
	OR6C76(23.9%)	exon1,c.932_933del,p.K311fs	0.239	0.02	1744|1151	616|23	0.29234	11905|4918	12	55820958	55820961	CAAA	CA	multiallelic	OR6C76	NM_001005183.1	1	c.932_933del	p.Lys311fs	frameshift_variant				42	0.0
	OR6C76(3.3%)	exon1,c.931_933del,p.K311del	0.033	0.001211	1744|167	616|0	0.04324	11905|538	12	55820958	55820961	CAAA	C	multiallelic	OR6C76	NM_001005183.1	1	c.931_933del	p.Lys311del	conservative_inframe_deletion				40	0.0
	OR6C76(26.5%)	exon1,c.933del,p.K311fs	0.265	0.154	1744|1267	616|158	0.31913	11905|5580	12	55820958	55820961	CAAA	CAA	multiallelic,Germline	OR6C76	NM_001005183.1	1	c.933del	p.Lys311fs	frameshift_variant				42	0.0
	OR6C76(6.5%)	exon1,c.933dup,p.H312fs	0.065	0.137	1744|326	616|144	0.17125	11905|2460	12	55820958	55820961	CAAA	CAAAA	multiallelic,suspected_bg	OR6C76	NM_001005183.1	1	c.933dup	p.His312fs	frameshift_variant				43	0.0
-	HNF1A(6.8%)	exon4,c.872del,p.P291fs	0.068	0.031	108|7	72|1	0.06704	167|12	12	121432117	121432118	GC	G	normal_artifact,slippage,distinguished	HNF1A	NM_000545.8	4	c.872del	p.Pro291fs	frameshift_variant	Pathogenic		Monogenic_diabetes|not_provided	27	0.0
-	BRCA2(1.6%)	exon10,c.1813del,p.I605fs	0.016	0.027	1601|31	542|16	0.02266	3494|81	13	32907420	32907421	GA	G	normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	10	c.1813del	p.Ile605fs	frameshift_variant	Pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Fanconi_anemia,_complementation_group_D1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|not_provided	28	0.0
-	BRCA2(1.3%)	exon11,c.2588dup,p.N863fs	0.013	0.004627	848|12	226|0	0.01037	1431|15	13	32911073	32911073	C	CA	PASS	BRCA2	NM_000059.4	11	c.2588dup	p.Asn863fs	frameshift_variant	Pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|not_provided	36	0.0
-	BRCA2(1.6%)	exon23,c.9097del,p.T3033fs	0.016	0.007608	1064|18	496|4	0.01258	2434|31	13	32954022	32954023	CA	C	multiallelic,normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	23	c.9097del	p.Thr3033fs	frameshift_variant	Pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided	29	0.0
-	BRCA2(2.7%)	exon23,c.9097dup,p.T3033fs	0.027	0.017	1064|37	496|11	0.02834	2434|71	13	32954022	32954023	CA	CAA	multiallelic,normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Carcinoma_of_breast|Neoplasm_of_ovary|Hereditary_breast_and_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial_1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|not_provided	38	0.0
	NBEA(1.2%)	exon22,c.3362dup,p.N1121fs	0.012	0.015	3294|64	1258|24	0.01912	9644|188	13	35733662	35733663	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	NBEA	NM_015678.5	22	c.3362dup	p.Asn1121fs	frameshift_variant	Likely_pathogenic		Neurodevelopmental_disorder_with_or_without_early-onset_generalized_epilepsy	39	0.0
-	RB1(3.5%)	exon7,c.608-4del	0.035	0.032	4155|181	2024|83	0.03102	24363|780	13	48934140	48934141	AT	A	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	6	c.608-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Retinoblastoma|Hereditary_cancer-predisposing_syndrome|not_provided	41	0.0
-	RB1(2.1%)	exon7,c.608-4dup	0.021	0.032	4155|114	2024|82	0.04173	24363|1061	13	48934140	48934141	AT	ATT	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	6	c.608-4dup		splice_region_variant&intron_variant	Benign		Retinoblastoma	39	0.0
	RB1(18.3%)	exon20,c.2020C>T,p.P674S	0.183	0.001045	6564|1450	3383|2	0.16654	41918|8376	13	49033883	49033883	C	T	PASS	RB1	NM_000321.3	20	c.2020C>T	p.Pro674Ser	missense_variant	Uncertain_significance		Retinoblastoma	41	0.0
	BCL2L2(9.9%)	exon4,c.463del,p.A155fs	0.099	0.029	82|7	41|0	0.09346	97|10	14	23778051	23778052	CG	C	PASS	BCL2L2	NM_001199839.2	4	c.463del	p.Ala155fs	frameshift_variant				61	0.0
	TSHR(21.9%)	exon10,c.2168del,p.K723fs	0.219	0.006381	615|171	444|2	0.18574	2284|521	14	81610566	81610567	CA	C	PASS	TSHR	NM_000369.5	10	c.2168del	p.Lys723fs	frameshift_variant				34	0.0
	PHGR1(13.1%)	exon4,c.135_200del,p.P46_P67del	0.131	0.032	99|4	90|1	0.00000	70|0	15	40648314	40648380	ACTGCGGGCCACCCCCTGGCCATGGCCCAGGGCCCTGCGGGCCACCCCCCCACCATGGTCCAGGGCC	A	slippage	PHGR1	NM_001145643.2	4	c.135_200del	p.Pro46_Pro67del	disruptive_inframe_deletion				21	0.0
	NTRK3(5.5%)	exon10,c.968T>C,p.F323S	0.055	0.045	71|4	22|0	0.04819	79|4	15	88678568	88678568	A	G	PASS	NTRK3	NM_001012338.3	10	c.968T>C	p.Phe323Ser	missense_variant				47	0.0
	BLM(3.1%)	exon7,c.1544del,p.N515fs	0.031	0.02	5612|223	3212|90	0.03548	28788|1059	15	91304138	91304139	GA	G	multiallelic,normal_artifact,slippage,suspected_bg	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		Bloom_syndrome	39	0.0
	BLM(2.2%)	exon7,c.1544dup,p.N515fs	0.022	0.025	5612|157	3212|99	0.03503	28788|1045	15	91304138	91304139	GA	GAA	multiallelic,normal_artifact,slippage,suspected_bg	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Bloom_syndrome|Hereditary_cancer-predisposing_syndrome	40	0.0
	CHD2(26.2%)	exon29,c.3734del,p.K1245fs	0.262	0.106	451|179	165|22	0.24413	805|260	15	93540315	93540316	GA	G	multiallelic,normal_artifact,distinguished	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Pathogenic/Likely_pathogenic		Developmental_and_epileptic_encephalopathy_94|History_of_neurodevelopmental_disorder|not_provided	44	0.0
	CHD2(4.0%)	exon29,c.3734dup	0.04	0.054	451|26	165|10	0.04734	805|40	15	93540315	93540316	GA	GAA	multiallelic,normal_artifact,suspected_bg	CHD2	NM_001271.4	29	c.3734dup		splice_donor_variant&intron_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Likely_benign(1)	Developmental_and_epileptic_encephalopathy_94	39	0.0
	CHD2(24.5%)	exon33,c.4173del,p.K1391fs	0.245	0.035	201|71	72|2	0.24685	299|98	15	93545433	93545434	GA	G	multiallelic,distinguished	CHD2	NM_001271.4	33	c.4173del	p.Lys1391fs	frameshift_variant	Likely_pathogenic		Intellectual_disability	35	0.0
	CHD2(2.2%)	exon33,c.4173dup,p.Q1392fs	0.022	0.083	201|5	72|6	0.04777	299|15	15	93545433	93545434	GA	GAA	multiallelic,suspected_bg	CHD2	NM_001271.4	33	c.4173dup	p.Gln1392fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(4)|_Uncertain_significance(1)	CHD2-Related_Disorder|Autistic_behavior|Seizure|Developmental_and_epileptic_encephalopathy_94|Complex_neurodevelopmental_disorder|not_provided	32	0.0
	SOCS1(34.9%)	exon2,c.563G>A,p.R188H	0.349	0.037	38|17	27|0	0.27143	51|19	16	11348773	11348773	C	T	PASS	SOCS1	NM_003745.1	2	c.563G>A	p.Arg188His	missense_variant				32	0.0
	PALB2(1.2%)	exon4,c.886del,p.M296*	0.012	0.013	1903|25	1054|12	0.01050	6976|74	16	23646980	23646981	AT	A	normal_artifact,background	PALB2	NM_024675.4	4	c.886del	p.Met296*	frameshift_variant&stop_gained	Pathogenic		Familial_cancer_of_breast|not_provided	20	0.0
	NUP93(14.9%)	exon9,c.852C>T,p.G284=	0.149	0.008072	427|76	158|0	0.14306	611|102	16	56862946	56862946	C	T	PASS	NUP93	NM_014669.5	9	c.852C>T	p.Gly284=	synonymous_variant				45	0.0
-	CDH1(0.3%)	exon3,c.377del,p.P126fs	0.003341	0.004278	6344|39	3272|27	0.00757	35678|272	16	68835780	68835781	GC	G	normal_artifact,weak_evidence,low_allele_frac	CDH1	NM_004360.5	3	c.377del	p.Pro126fs	frameshift_variant	Pathogenic		Hereditary_diffuse_gastric_cancer|not_provided	36	0.0
	PLCG2(17.5%)	exon3,c.246C>T,p.F82=	0.175	0.03	236|54	82|1	0.17191	342|71	16	81888101	81888101	C	T	PASS	PLCG2	NM_002661.5	3	c.246C>T	p.Phe82=	synonymous_variant	Likely_benign		Familial_cold_autoinflammatory_syndrome_3	40	0.0
	PLCG2(15.9%)	exon12,c.1072+2T>C	0.159	0.059	53|10	19|0	0.12857	61|9	16	81927401	81927401	T	C	PASS	PLCG2	NM_002661.5	12	c.1072+2T>C		splice_donor_variant&intron_variant				46	0.0
-	NF1(3.5%)	exon2,c.61-4del	0.035	0.036	533|21	100|2	0.02295	809|19	17	29482988	29482989	CT	C	normal_artifact,slippage,suspected_bg	NF1	NM_000267.3	1	c.61-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Neurofibromatosis,_familial_spinal|Caf??-au-lait_macules_with_pulmonary_stenosis|Neurofibromatosis-Noonan_syndrome|Neurofibromatosis,_type_1|not_specified|not_provided	46	0.0
	KRTAP4-7(9.4%)	exon1,c.321C>A,p.P107=	0.094	0.031	155|22	49|1	0.12105	334|46	17	39240779	39240779	C	A	clustered_events,haplotype,background	KRTAP4-7	NM_033061.3	1	c.321C>A	p.Pro107=	synonymous_variant				11	0.0
	KRTAP4-7(8.7%)	exon1,c.333C>T,p.R111=	0.087	0.035	103|13	33|0	0.06918	296|22	17	39240791	39240791	C	T	clustered_events,haplotype,background	KRTAP4-7	NM_033061.3	1	c.333C>T	p.Arg111=	synonymous_variant				6	0.0
	BRCA1(3.2%)	exon10,c.3772_3774del,p.E1258del	0.032	0.00437	1057|34	271|0	0.02348	1788|43	17	41243773	41243776	TCTC	T	PASS	BRCA1	NM_007294.4	10	c.3772_3774del	p.Glu1258del	conservative_inframe_deletion	Uncertain_significance		Hereditary_breast_and_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial_1|Hereditary_cancer-predisposing_syndrome|not_provided	35	0.0
	XYLT2(19.1%)	exon8,c.1584del,p.G529fs	0.191	0.025	1151|269	781|23	0.18544	2618|596	17	48433966	48433967	AC	A	normal_artifact,distinguished	XYLT2	NM_022167.4	8	c.1584del	p.Gly529fs	frameshift_variant	Likely_pathogenic		Spondyloocular_syndrome	40	0.0
	GNA13(17.6%)	exon2,c.451G>A,p.A151T	0.176	0.035	125|24	31|0	0.17112	155|32	17	63049679	63049679	C	T	PASS	GNA13	NM_006572.6	2	c.451G>A	p.Ala151Thr	missense_variant				48	0.0
-	SOX9(19.7%)	exon3,c.788dup,p.R264fs	0.197	0.054	16|4	17|0	0.17857	23|5	17	70119780	70119780	A	AG	PASS	SOX9	NM_000346.4	3	c.788dup	p.Arg264fs	frameshift_variant	Pathogenic		Campomelic_dysplasia_with_autosomal_sex_reversal	21	0.0
	RPTOR(16.0%)	exon16,c.1707G>A,p.P569=	0.16	0.056	27|6	22|0	0.15385	33|6	17	78857637	78857637	G	A	PASS	RPTOR	NM_020761.3	16	c.1707G>A	p.Pro569=	synonymous_variant				58	0.0
-	SMAD2(3.3%)	exon5,c.524del,p.L175fs	0.033	0.00278	1443|52	418|0	0.02998	2815|87	18	45394824	45394825	CA	C	PASS	SMAD2	NM_005901.6	5	c.524del	p.Leu175fs	frameshift_variant				38	0.0
	STK11(11.1%)	exon9,c.1213A>G,p.R405G	0.111	0.026	27|3	37|0	0.08333	33|3	19	1226557	1226557	A	G	PASS	STK11	NM_000455.5	9	c.1213A>G	p.Arg405Gly	missense_variant	Uncertain_significance		Peutz-Jeghers_syndrome|Hereditary_cancer-predisposing_syndrome	63	0.0
	BAX(4.5%)	exon3,c.121del,p.E41fs	0.045	0.03	1646|87	640|21	0.03219	4179|139	19	49458970	49458971	TG	T	normal_artifact,slippage,suspected_bg	BAX	NM_138761.4	3	c.121del	p.Glu41fs	frameshift_variant	Pathogenic		Carcinoma_of_colon	46	0.0
	NCOA6(17.1%)	exon7,c.828_830del,p.Q277del	0.171	0.008809	1513|316	594|8	0.16183	5086|982	20	33345720	33345726	TTGCTGC	TTGC	clustered_events,multiallelic,distinguished	NCOA6	NM_014071.5	7	c.828_830del	p.Gln277del	disruptive_inframe_deletion	Likely_benign		not_provided	54	0.0
	ADNP(0.2%)	exon6,c.3037G>A,p.A1013T	0.002147	0.0009454	7209|15	3593|4	0.00117	35772|42	20	49508214	49508214	C	T	low_allele_frac	ADNP	NM_001282531.3	6	c.3037G>A	p.Ala1013Thr	missense_variant				45	0.0
	CRKL(1.1%)	exon3,c.854T>C,p.L285P	0.011	0.004117	1177|14	318|0	0.02079	2120|45	22	21304075	21304075	T	C	PASS	CRKL	NM_005207.4	3	c.854T>C	p.Leu285Pro	missense_variant				35	0.0
	NEFH(12.1%)	exon4,c.1965_1988del,p.E656_P663del	0.121	0.063	116|13	16|0	0.00000	49|0	22	29885580	29885604	AAGGCCAAGTCCCCAGAGAAGGAAG	A	PASS	NEFH	NM_021076.4	4	c.1965_1988del	p.Glu656_Pro663del	disruptive_inframe_deletion	Benign/Likely_benign		Inborn_genetic_diseases|not_provided	28	0.0
	MED12(9.3%)	exon42,c.6165_6167del,p.Q2056del	0.093	0.052	40|4	15|0	0.04000	96|4	X	70360588	70360591	GAGC	G	slippage,distinguished	MED12	NM_005120.3	42	c.6165_6167del	p.Gln2056del	disruptive_inframe_deletion	Uncertain_significance		FG_syndrome_1	49	0.0
